ArticleApplied biochemistry and biotechnology2026
Deciphering Melatonin-Driven Bioenergy Reprogramming Through Integrated Physiological and Metabolomic Analyses in Dunaliella salina.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite their immense promise as renewable bioenergy resources, microalgae continue to face major barriers to industrial deployment due to low biomass output and constrained lipid accumulation. In this regard, the regulatory role of melatonin (MT) in modulating carbon flux allocation and redox homeostasis was investigated in the oleaginous, D. salina using a two-stage cultivation strategy. During Stage I, supplementation with 20 µM MT enhanced biomass accumulation and chlorophyll a content relative to the control. However, during Stage II, MT supplementation triggered pronounced metabolic reprogramming, leading to substantial enrichment of lipids (41.6%) and carbohydrates (17.52%), accompanied by a concomitant decline in protein content under nitrogen starvation. This metabolic shift was coupled with strong activation of the antioxidant defense system, as evidenced by elevated SOD, CAT, and APX activities, while DCFDA-based flow cytometric analysis revealed a tightly regulated ROS profile, indicative of maintained redox homeostasis. In addition, FTIR spectroscopy showed increased absorbance at 2929 cm⁻¹, and 1726 cm⁻¹, corroborating neutral lipid enrichment. Interestingly, untargeted HR-MS-based metabolomics further revealed a pronounced upregulation of fatty acid biosynthesis pathways, accompanied by enrichment of saturated fatty acids and a concomitant reduction in polyunsaturated fatty acids. These findings indicate that MT coordinates a finely tuned redox-metabolic network in which controlled ROS dynamics, together with reinforced antioxidant defense, synergistically redirect carbon flux toward neutral lipid biosynthesis. This study provides mechanistic insights into MT-mediated biochemical engineering and highlights its potential to enhance the commercial feasibility of vehicular grade biofuel production.
Indexed as
Identifiers
42390732What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.